Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Paola Frati
Observed names:
Frati, Paola,
P. Frati
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
University of Siena,
University of Milan,
Istituto Oncologico Veneto,
Fondazione IRCCS Istituto Nazionale dei Tumori,
University of Milano-Bicocca
ORCID:
0000-0002-1242-173X
Observed ORCID:
0000-0002-1242-173X
OpenAlex ID:
A5023762347
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
2015
·
Elisabetta Vergani
, Lorenza Di Guardo
, et al.
·
Oncotarget
·
111
Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides
2012
·
Paola Filipazzi
, Lorenzo Pilla
, et al.
·
Clinical Cancer Research
·
78
Y 90 -radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers
2022
·
Licia Rivoltini
, Sherrie Bhoori
, et al.
·
Gut
·
41
PDF
Transcriptional Profiling of Melanoma Sentinel Nodes Identify Patients with Poor Outcome and Reveal an Association of CD30+ T Lymphocytes with Progression
2014
·
Viviana Vallacchi
, Elisabetta Vergani
, et al.
·
Cancer Research
·
39
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients
2021
·
Veronica Huber
, Lorenza Di Guardo
, et al.
·
Journal for ImmunoTherapy of Cancer
·
20
PDF
The Critical Role of the Clinical Research Coordinator for Clinical Trials: A Survey in Oncology
2017
·
Margherita Cinefra
, Celeste Cagnazzo
, et al.
·
Medicine Access Point of Care
·
19
PDF
Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis
2024
·
Elena Daveri
, Barbara Vergani
, et al.
·
Journal for ImmunoTherapy of Cancer
·
18
PDF
Clinical Trial Units in Italy: the perception of the Clinical Research Coordinators
2016
·
C. Cagnazzo
, O. Nanni
, et al.
·
Annals of Oncology
·
3
PDF
A platform for high-resolution immune liquid biopsy analysis to predict response in patients with renal cell carcinoma treated with nivolumab or cabozantinib: Preliminary data from I-RENE trial (Meet-URO 8 study).
2023
·
Elena Verzoni
, Veronica Huber
, et al.
·
Journal of Clinical Oncology
·
2
PDF
AIFA Determination 809/2015 on Phase I Clinical Trials: a new challenge for Italian Research
2016
·
E. Marchesi
, M. Monti
, et al.
·
Annals of Oncology
·
2
PDF
2641P Systemic immunosuppressive and pro-inflammatory milieu associates with poor prognosis and resistance to therapy in metastatic Collecting Duct (CDC) carcinoma patients
2025
·
E. Verzoni
, E. Gusmaroli
, et al.
·
Annals of Oncology
Correction: Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
2025
·
Elisabetta Vergani
, Lorenza Di Guardo
, et al.
·
Oncotarget
PDF
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center
2022
·
Giovanni Fucà
, Mara Lecchi
, et al.
·
Therapeutic Advances in Medical Oncology
PDF
Phase I cancer clinical trials in Italy: state of the art and future challenges
2016
·
L. Mcmahon
, C. Cagnazzo
, et al.
·
Annals of Oncology
PDF
Frequency of BRAF V600E variant in circulating free DNA compared with the single melanoma biopsy.
2013
·
Lorenza Di Guardo
, Viviana Vallacchi
, et al.
·
Journal of Clinical Oncology
Amianto Ed Insorgenza Di Mesotelioma: Case Report
2013
·
T Caciari
, T Casale
, et al.
Show more works
View as search
Works count:
18
Citation count:
333
H-index:
7
I10-index:
7
Year
Topic
Type